Sprint Bioscience
Pre-clinicalSprint Bioscience is a pharmaceutical company focused on developing innovative drug candidates that can contribute to new treatments for cancer. The great need for new treatments for difficult-to-treat cancer brings great commercial potential.Using a fragment-based drug development approach, we develop drug programs in a time- and resource-efficient manner that are out-licensed to global pharmaceutical companies during the preclinical phase.
About
Sprint Bioscience is a pharmaceutical company focused on developing innovative drug candidates that can contribute to new treatments for cancer. The great need for new treatments for difficult-to-treat cancer brings great commercial potential.Using a fragment-based drug development approach, we develop drug programs in a time- and resource-efficient manner that are out-licensed to global pharmaceutical companies during the preclinical phase.
Funding History
4Total raised: $47.5M
Company Info
Contact
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile